Results 41 to 50 of about 15,916,923 (301)

The processes of reform in Victoria’s alcohol and other drug sector, 2011-2014 [PDF]

open access: yes, 2014
This paper explores issues and concerns related to the 2014 alcohol and other drug sector recommissioning process in Victoria. Overview In mid-2014, the Victorian Alcohol and Drug Association approached the Drug Policy Modelling Program, at the ...
Drug Policy Modelling Program
core  

Drug-related and drug-misuse deaths 2009-2019.

open access: yes, 2021
There were 191 drug-related deaths registered in Northern Ireland in 2019. Almost half (45.5%) of these deaths were of men aged 25-44. These are some of the findings of the statistics published today by the Northern Ireland Statistics and Research Agency

core  

Organoids in pediatric cancer research

open access: yesFEBS Letters, EarlyView.
Organoid technology has revolutionized cancer research, yet its application in pediatric oncology remains limited. Recent advances have enabled the development of pediatric tumor organoids, offering new insights into disease biology, treatment response, and interactions with the tumor microenvironment.
Carla Ríos Arceo, Jarno Drost
wiley   +1 more source

AN INVESTIGATION INTO THE VALUE OF A STANDARDISED GLOBAL PHARMACOVIGILANCE REPORTING SYSTEM

open access: yesSouth African Journal of Industrial Engineering, 2017
Pharmacovigilance (PV) is based on the medical assessment of adverse medical events or drug-related problems, collected within organised health programmes.
Schurer, Maximillian Juan   +2 more
doaj   +1 more source

Microbiome−host proteostasis crosstalk—An emerging perspective on mechanisms and interventions toward healthy longevity

open access: yesFEBS Letters, EarlyView.
Proteostasis and the gut microbiota play a key role in shaping host physiology. Microbiota‐derived metabolites, vitamins, and RNA modulate host proteostasis. Findings from model systems, including C. elegans, indicate microbes can either stabilize or disrupt host proteostasis.
Abhishek Anil Dubey, Maria Ermolaeva
wiley   +1 more source

Identification of drug-related problems and pharmacist′s interventions in asthmatic patients at a private tertiary care facility-Pakistan

open access: yesArchives of Pharmacy Practice, 2015
Background: Drug-related problems (DRPs) potentially contribute to morbidity, mortality and financial indicators. There is increasing evidence that participation and interventions of clinical pharmacists in health care have a positive influence on ...
Aziz Ullah Khan   +3 more
doaj   +1 more source

Overview of drug-related problems (DRPs) at hospitalization, identified by clinical pharmacists, in patients with drug-related hospitalization (DRH) versus non-drug-related hospitalizations (non-DRHs) in the study population (n = 395a).

open access: yes, 2019
Overview of drug-related problems (DRPs) at hospitalization, identified by clinical pharmacists, in patients with drug-related hospitalization (DRH) versus non-drug-related hospitalizations (non-DRHs) in the study population (n = 395a).
Kristin Kvernrød (7022792)   +5 more
core   +1 more source

Design and analysis strategies for robust microbiome ageing research

open access: yesFEBS Letters, EarlyView.
The gut microbiome changes with age and associates with age‐related morbidity and mortality, establishing it as a potential biomarker and intervention target for ageing. Realising this potential requires methodological rigour, yet distinguishing biological signals from methodological artefacts remains challenging across cohorts. This review provides an
Mark Olenik   +5 more
wiley   +1 more source

Drug-Related Problems in Pulmonary Hypertension with Valvular Heart Disease

open access: yes, 2022
Farizan Abdul-Ghaffar,1,2 Adyani Md Redzuan,1 Mohd Makmor-Bakry,1 Mohamad Arif Muhamad Nor3 1Faculty of Pharmacy, Universiti Kebangsaan Malaysia, Kuala Lumpur, Malaysia; 2Department of Pharmacy, Hospital Serdang, Kajang, Malaysia; 3Department of ...
Md Redzuan A   +3 more
core  

Engineering peptides into antibodies—opportunities and strategies for therapeutic innovation

open access: yesFEBS Letters, EarlyView.
Peptides and antibodies occupy complementary therapeutic niches. Peptides recognize difficult targets in a compact format, while antibodies add specificity, long half‐life, and effector functions. This review examines strategies that merge both modalities—peptide grafting into loops, terminal and Fc fusions, and bioconjugation—highlighting how ...
Jinling Wang   +2 more
wiley   +1 more source

Home - About - Disclaimer - Privacy